Universal-Beteiligungs- und Servicegesellschaft
ANIP icon

Universal-Beteiligungs- und Servicegesellschaft’s ANI Pharmaceuticals ANIP Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
3,448
+367
+12% +$29.4K ﹤0.01% 1943
2026
Q1 		$237K Sell
3,081
-267
-8% -$20.8K ﹤0.01% 1943
2025
Q4 		$264K Sell
3,348
-38,844
-92% -$3.36M ﹤0.01% 1902
2025
Q3 		$3.86M Sell
42,192
-22,419
-35% -$1.83M 0.01% 991
2025
Q2 		$4.22M Buy
64,611
+7,947
+14% +$517K 0.01% 896
2025
Q1 		$3.79M Buy
+56,664
New +$3.38M 0.01% 910

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's ANIP Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its ANI Pharmaceuticals (ANIP) stake by 12% in Q2 2026, buying an estimated $29.4K and bringing the position to 3,448 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #1943.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ANIP in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.22M in Q2 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 3,448 shares of ANI Pharmaceuticals worth $285K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 367 ANI Pharmaceuticals shares in Q2 2026, an estimated $29.4K.
  • ANI Pharmaceuticals made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1943 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in ANI Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's ANI Pharmaceuticals position peaked at $4.22M in Q2 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.